Onderneming Nascent Biotech, Inc. Other OTC
Aandelen
NBIO
US63108Q1013
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 56 | 15-07-14 |
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15-07-14 |
Douglas Karas
BRD | Director/Board Member | 59 | 04-04-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15-07-14 |
Sean Carrick
CEO | Chief Executive Officer | 56 | 15-07-14 |
Douglas Karas
BRD | Director/Board Member | 59 | 04-04-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 169 729 565 | 101 841 640 ( 60,00 %) | 0 | 60,00 % |
Bedrijfsgegevens
Nascent Biotech, Inc.
623 US Highway 1 Suite 407
33408, North Palm Beach
+
http://www.nascentbiotech.com![Adres Nascent Biotech, Inc.(NBIO)](https://cdn.zonebourse.com/static/address/18088236.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,49% | 122 mld. | |
+21,73% | 115 mld. | |
+22,88% | 26,64 mld. | |
-21,81% | 19,91 mld. | |
-16,75% | 16,32 mld. | |
-18,81% | 15,49 mld. | |
-44,74% | 15,52 mld. | |
+62,72% | 14,83 mld. | |
+3,09% | 13,67 mld. |